CD320 receptor and vitamin B12 as potential targets for anti-cancer therapy
Tolymbekova A, Lezina L (2025) CD320 receptor and vitamin B12 as potential targets for anti-cancer therapy. Int J Mol Sci 26(12):5652. doi: 10.3390/ijms26125652 PMID: 40565117 Objective: To develop therapies discriminating between healthy and cancerous cells to prevent unwanted toxicity of anticancer agents. Summary: One possible method is to target proteins overexpressed in cancer but not […]
CD320 receptor and vitamin B12 as potential targets for anti-cancer therapy Read More »
